(Q93616834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4044751%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

title

Assay of nadolol in serum by reversed-phase high-performance liquid chromatography with fluorometric detection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4044751%20AND%20SRC:MED&resulttype=core&format=json

high-performance liquid chromatography

8 May 2020

main subject

1 reference

J Moncrieff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4044751%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

publication date

1 July 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4044751%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

volume

342

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4044751%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4044751%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

page(s)

206-211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4044751%20AND%20SRC:MED&resulttype=core&format=json

Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate)

8 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984505-3

7 January 2021

Metabolic Studies in Patients with Nadolol: Oral and Intravenous Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984505-3

7 January 2021

High-pressure liquid chromatography of nadolol and other beta-adrenergic blocking drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984505-3

7 January 2021

Fluorometric Determination of Nadolol in Human Serum and Urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984505-3

7 January 2021

Determination of Serum Nadolol Levels by GLC–Selected Ion Monitoring Mass Spectrometry: Comparison with a Spectrofluorometric Method

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984505-3

7 January 2021

Fluorodensitometric determination of nadolol in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984505-3

7 January 2021

Feasibility of determining nadolol in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984505-3

7 January 2021

Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography. Five commonly used beta blockers and hydralazine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984505-3

7 January 2021

Ion-exchange high-performance liquid chromatography in drug assay in biological fluids. III. Propranolol, nadolol and prazosin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984505-3

7 January 2021

10.1016/S0378-4347(00)84505-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4044751%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

1 reference